GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Search Inside the pdf :

GKB Ophthalmics Ltd.

03 Nov 2025

66.90

1.38%

AGM

GKB Ophthalmics Ltd - 533212 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot

BSE India

This is with reference to our later dated September 30,2025 Wherein the Company had sought the Consent of its member through Postal Ballot by remote evoting vide Postal Ballot Notice dated September 22, 2025. The Resolutions have been passed by the Members with requisite majority and are deemed to have been passed on Saturday , November 01, 2025, being the last date specified for the Remote E-voting process. This intimation shall also be deemed to be a disclosure of the proceedings under Regulation 30 read with Clause 13 of Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015, as amended

pdf

GKB Ophthalmics Ltd.

03 Nov 2025

66.90

1.38%

AGM

GKB Ophthalmics Ltd - 533212 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Pursuant to Section 110 of the Companies Act, 2013 read with Rule 22 of Companies (Management and Administration) Rules, 2014 and Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations ,2015, please find enclosed herewith the Srutinizer''s Report. Further the Company received a letter dated October 31, 2025, from one shareholder ( no. of shares 1,34,218 as on cut off date ) stating that inadvertently, the votes were cast in dissent of resolution no. 1 whereas the assent was correctly given at resolution no.2 which is linked to resolution no. 1 and requested the management to consider the votes in favour of the said resolution. Accordingly based on the letter, the said shareholder''s votes on resolution no. 1 were taken on record as votes cast in favour. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

28 Oct 2025

66.90

1.38%

Board Meeting

GKB Ophthalmics Ltd - 533212 - Board Meeting Intimation for Approval Of Unaudited Financial Results For …

BSE India

GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025. The Notice can be accessed at the Company''s Website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI ( Prohibition of Insider Trading) Regulations, 2015, had been closed from October 01, 2025, will now re-open after the completion of 48 hours from the date of submission of financial results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.

pdf

GKB Ophthalmics Ltd.

11 Oct 2025

66.90

1.38%

Company Update

GKB Ophthalmics Ltd - 533212 - Intimation Of Reduction In Production And Manpower At The Company''s …

BSE India

In Compliance with Regulation 30 read with Schedule III Part A Para B of SEBI ( Listing Obligations and Disclosure Requirements) Regulation ,2015, corporate announcement is hereby given that the Company''s Plant at Tivim Industrial Estate, Mapusa, Goa, has gradually reduced its production to 50% on account of fewer number of orders due to sluggish market demand and the Complete stoppage of export orders from our Subsidiary Company in USA from the month of October 2025 onwards, due to heavy imposition of tariffs. Further the Company is being reducing its manpower by releasing its temporary workers in a phased manner in order to cut down its labour cost. The Comply will review its situation in the coming months and accordingly plan its business operations.

pdf

GKB Ophthalmics Ltd.

06 Oct 2025

66.90

1.38%

Company Update

GKB Ophthalmics Ltd - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30,2025. Kindly acknowledge receipt of the same.

pdf

GKB Ophthalmics Ltd.

03 Oct 2025

66.90

1.38%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find enclosed the newspaper advertisements published in The Times of India, Goa Edition dated October 01,2025 and Pudhari (Marathi Edition) dated October 01, 2025 in connection with completion of dispatch of Postal Ballot Notice. Please acknowledge receipt.

pdf

GKB Ophthalmics Ltd.

30 Sep 2025

66.90

1.38%

AGM

GKB Ophthalmics Ltd - 533212 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Pursuant to Regulation 30, enclosed please find the Postal Ballot Notice dated September 22, 2025, for seeking the approval of the members by way of Ordinary and Special Resolutions, respectively for the following items of business: 1. Prior approval of Related Party Transaction pursuant to Regulation 23 of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 2. Approval of the proposal of voluntary winding up of Material Subsidiary, GSV Ophthalmics Private Limited. The Notice of the Postal Ballot is available on the website of the Company at www.gkb.net , on the website of the stock exchange i.e., BSE Limited at www.bseindia.com and on the website of CDSL at www.evotingindia.com. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

27 Sep 2025

66.90

1.38%

SAST

GKB Ophthalmics Ltd - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading ) Regulations 2015, as amended from time to time, the "Trading Window" for dealing/trading in the shares of the Company shall remain close from October 01, 2025, till the completion of 48 hours after the declaration of the financial results of the Company, for the quarter and half year ended September 30, 2025. Accordingly, all the Promoters, Directors and Designated persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Further , the date of Board Meeting at which the said results will be considered , shall be intimated in due course of time. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

22 Sep 2025

66.90

1.38%

Company Update

GKB Ophthalmics Ltd - 533212 - Intimation And Board Outcome Regarding Voluntary Liquidation Of Material Subsidiary …

BSE India

Pursuant to Regulation of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2025, we wish to inform that : 1. Intimation from Material Subsidiary proposing to initiate Voluntary Liquidation under Section 59 of Insolvency and Bankruptcy Code 2016. 2. Outcome of the Board Meeting of the Company held on September 22, 2025 which reviewed and approved the proposal of voluntary winding up of its subsidiary subject to approval of the shareholders. Enclose please find the details in this regard. The Board of Directors'' meeting started at 4.30 P.M. and ended at 5.15 P.M. , on the same day.

pdf

GKB Ophthalmics Ltd.

17 Sep 2025

66.90

1.38%

SAST

GKB Ophthalmics Ltd - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, as the designated persons are reasonably expected to be in possession of unpublished price sensitive information, the "Trading Window" for dealing/trading in the shares of the Company shall remain close from September 22, 2025, till the Completion of 48 hours after the disclosure of the outcome of the Board meeting of the Company to be held on the said date, for noting the proposal of winding up of its material subsidiary, GSV Ophthalmics Private Limited which remains non operational since its inception. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of Closure of Trading Window. Kindly take the information on record.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%